ARS Pharmaceuticals (NASDAQ:SPRY) Posts Earnings Results, Beats Estimates By $0.61 EPS
ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.61, Zacks reports. ARS Pharmaceuticals Price Performance NASDAQ SPRY traded up $2.82 on Thursday, reaching $14.47. 4,254,858 shares of the company’s stock traded hands, […]
20 Mar 15:10 · The Markets Daily